CA125 levels tend to be higher in patients with CCC and other EOC subtypes than in patients with benign ovarian tumors, borderline ovarian tumors, or Ut disease; consequently, CA125 is the gold-standard biomarker for EOC (Fig 1A and Table 3). Here, MUC16 is linked to ovarian benign neoplasm.